NCT00420381 2020-12-19Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal CancerEli Lilly and CompanyPhase 2 Completed28 enrolled 13 charts
NCT00309140 2020-06-26An Open Label Study of Oral Enzastaurin in Participants With CancerEli Lilly and CompanyPhase 2 Completed23 enrolled 13 charts
NCT01445119 2013-08-28A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent GliomasEli Lilly and CompanyPhase 1 Completed58 enrolled